AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Fingers point to activity trackers on smartwatches

Which specialties lead the way on using wearable data for care

| 7 Min Read
Stethoscope hanging on railing inside hospital

4 top factors that drive physicians to give up clinical practice

| 5 Min Read
Senior man using a phone at a clinic

CMS ACCESS Model launches in July: What doctors should know

| 5 Min Read
Chelsea Evans, DO, featured on "Health vs. Hype" AMA podcast

4 things to know about cold plunges and contrast therapy

| 5 Min Read